rhTNK-tPA (recombinant human TNK tissue-type plasminogen activator)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rhTNK-tPA (recombinant human TNK tissue-type plasminogen activator), covering 2024-03-19 to 2024-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization [Phase 4]